OTC Markets Group Posts Strong Q1 2026 Growth as Revenue, Trading Activity, and Earnings Rise

OTC Markets Group Inc. reported a strong first quarter of 2026, supported by higher trading activity, steady demand for market data, and growth in corporate services. The company said gross revenue reached $34.8 million, up 14% from the same period last year, while operating income rose 19% to $8.6 million. Net income increased 17% to $7.1 million.

Strong Start to 2026

The first quarter showed that OTC Markets Group continued to benefit from its diversified business model. Its three main areas—OTC Link, Market Data Licensing, and Corporate Services—each contributed to growth. Management described the quarter as a record period, with OTC Link showing the fastest improvement.

OTC Link revenue increased 31% year over year, helped by stronger trading volumes across the company’s markets. The company reported about $230 billion in dollar volume traded, nearly 30% higher than the same quarter in 2025.

Financial Highlights

For the quarter ended March 31, 2026, OTC Markets Group reported revenue less transaction-based expenses of $30.4 million, up 12%. Operating margin improved to 25.5%, compared with 24.7% a year earlier. Diluted GAAP earnings were $0.59 per share, up 18%, while adjusted diluted earnings were $0.93 per share, up 15%.

Trading Activity Drives OTC Link Growth

Trading activity was one of the biggest drivers of the quarter. Average daily trades on OTC Link ECN and OTC Link NQB reached about 96,000, a 78% increase from the prior-year period. The company’s overnight trading platform, MOON ATS, also showed strong activity, averaging about 71,000 trades and 7.2 million shares traded per session.

Management said MOON ATS has become a useful contributor to transaction-based revenue, although the company is not yet breaking out its exact revenue contribution. Executives also noted that competition in overnight trading could increase as major exchanges enter the space later in the year.

Market Data and Corporate Services Continue to Expand

Market Data revenue rose 2%, supported by growth in enterprise and professional users, as well as targeted price increases for selected products. Management said long-term success in this area depends not only on pricing but also on improving product features, expanding distribution, and increasing user engagement.

Corporate Services revenue grew 19%, continuing momentum from late 2025. The company said this business benefited from demand for disclosure tools, issuer services, and new market-tier offerings such as OTCID.

Costs Rise as Company Invests in Technology and Compliance

Operating expenses increased 10% from the prior year. Compensation and benefits rose 9%, IT infrastructure and information services costs increased 16%, and professional and consulting fees climbed 29%. Management linked these increases to cloud migration, product testing, regulatory costs, clearing-related expenses, and higher trading activity.

Executives made clear that these costs are part of running and improving the business. They also said investments in cloud systems, data sets, and trading infrastructure are important for long-term growth.

Shareholder Returns Increase

OTC Markets Group returned $6.8 million to shareholders during the quarter. This included $3.6 million in dividends and $3.1 million in share repurchases, representing a 33% increase from the prior-year period.

Management said the company remains focused on creating long-term value for shareholders rather than making short-term moves to influence the stock price.

Asia-Pacific Expansion Becomes a Strategic Focus

The company also highlighted its Asia-Pacific growth plans. OTC Markets Group recently launched a Hong Kong team to support regional expansion. Management said the goal is to build relationships with local broker-dealers, expand market data distribution, support overnight trading, and educate international companies about U.S. market access.

This strategy could help the company reach more issuers and investors in Asia, where public markets continue to grow and corporate disclosure standards are improving.

Management Discusses Disclosure and Regulation

During the earnings call, management also discussed a recent SEC proposal that could allow some public companies to move from quarterly to semiannual reporting. OTC Markets Group said it supports efforts to reduce unnecessary burdens on public companies, but also stressed the importance of investor transparency and market integrity.

The company described itself as a disclosure-based market and said it would watch the public comment process closely before deciding how any rule changes might affect its own markets.

Outlook

OTC Markets Group entered 2026 with strong momentum. Growth in OTC Link, higher trading volumes, improving corporate services demand, and early progress in overnight trading all helped the company deliver a solid quarter. At the same time, management warned that trading volumes can be unpredictable and that competition may shift as more firms enter overnight trading.

Overall, the company appears focused on steady expansion, technology upgrades, better market transparency, and international growth. Its first-quarter results show strong execution, but future performance will depend on trading activity, regulatory developments, customer adoption, and the success of newer initiatives such as MOON ATS and Asia-Pacific expansion.

#OTCMarkets #OTCM #EarningsNews #StockMarket #SlimScan #GrowthStocks #CANSLIM